Novel nongenetic murine model of hyperglycemia and hyperlipidemia-associated aggravated atherosclerosis

• Verfasst von: Gaul, Susanne [VerfasserIn]
• Verfasst von: Shahzad, Khurrum [VerfasserIn]
• Verfasst von: Medert, Rebekka [VerfasserIn]
• Verfasst von: Gadi, Ihsan [VerfasserIn]
• Verfasst von: Mäder, Christina [VerfasserIn]
• Verfasst von: Schumacher, Dagmar [VerfasserIn]
• Verfasst von: Wirth, Angela [VerfasserIn]
• Verfasst von: Ambreen, Saira [VerfasserIn]
• Verfasst von: Fatima, Sameen [VerfasserIn]
• Verfasst von: Boeckel, Jes-Niels [VerfasserIn]
• Verfasst von: Khawaja, Hamzah [VerfasserIn]
• Verfasst von: Haas, Jan [VerfasserIn]
• Verfasst von: Brune, Maik [VerfasserIn]
• Verfasst von: Nawroth, Peter Paul [VerfasserIn]
• Verfasst von: Isermann, Berend [VerfasserIn]
• Verfasst von: Laufs, Ulrich [VerfasserIn]
• Verfasst von: Freichel, Marc [VerfasserIn]
• Titel: Novel nongenetic murine model of hyperglycemia and hyperlipidemia-associated aggravated atherosclerosis
• Verf.angabe: Susanne Gaul, Khurrum Shahzad, Rebekka Medert, Ihsan Gadi, Christina Mäder, Dagmar Schumacher, Angela Wirth, Saira Ambreen, Sameen Fatima, Jes-Niels Boeckel, Hamzah Khawaja, Jan Haas, Maik Brune, Peter P. Nawroth, Berend Isermann, Ulrich Laufs and Marc Freichel
• E-Jahr: 2022
• Jahr: 08 March 2022
• Umfang: 20 S.
• Fussnoten: Specialty section: This article was submitted to Atherosclerosis and Vascular Medicine, a section of the journal Frontiers in Cardiovascular Medicine ; Gesehen am 07.07.2022
• Titel Quelle: Enthalten in: Frontiers in Cardiovascular Medicine
• Ort Quelle: Lausanne : Frontiers Media, 2014
• Jahr Quelle: 2022
• Band/Heft Quelle: 9(2022) vom: März, Artikel-ID 813215, Seite 1-20
• ISSN Quelle: 2297-055X
• DOI: doi:10.3389/fcvm.2022.813215
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1809414903
• K10plus-PPN:
  Universitätsbibliothek
• Lokale URL UB: Zum Volltext

Abstract

Objective: Atherosclerosis, the main pathology underlying cardiovascular diseases is accelerated in diabetic patients. Genetic mouse models require breeding efforts which are time-consuming and costly. Our aim was to establish a new nongenetic model of inducible metabolic risk factors that mimics hyperlipidemia, hyperglycemia, or both and allows the detection of phenotypic differences dependent on the metabolic stressor(s). Methods and Results: Wild-type mice were injected with gain-of-function PCSK9D377Y (proprotein convertase subtilisin/kexin type 9) mutant adeno-associated viral particles (AAV) and streptozotocin and fed either a high-fat diet (HFD) for 12 or 20 weeks or a high-cholesterol/high-fat diet (Paigen diet, PD) for 8 weeks. To evaluate atherosclerosis, two different vascular sites (aortic sinus and the truncus of the brachiocephalic artery) were examined in the mice. Combined hyperlipidemic and hyperglycemic (HGHCi) mice fed a HFD or PD displayed characteristic features of aggravated atherosclerosis when compared to hyperlipidemia (HCi HFD or PD) mice alone. Atherosclerotic plaques of HGHCi HFD animals were larger, showed a less stable phenotype (measured by the increased necrotic core area, reduced fibrous cap thickness, and less α-SMA-positive area) and had more inflammation (increased plasma IL-1β level, aortic pro-inflammatory gene expression, and MOMA-2-positive cells in the BCA) after 20 weeks of HFD. Differences between the HGHCi and HCi HFD models were confirmed using RNA-seq analysis of aortic tissue, revealing that significantly more genes were dysregulated in mice with combined hyperlipidemia and hyperglycemia than in the hyperlipidemia-only group. The HGHCi-associated genes were related to pathways regulating inflammation (increased Cd68, iNos, and Tnfa expression) and extracellular matrix degradation (Adamts4 and Mmp14). When comparing HFD with PD, the PD aggravated atherosclerosis to a greater extent in mice and showed plaque formation after 8 weeks. Hyperlipidemic and hyperglycemic mice fed a PD (HGHCi PD) showed less collagen (Sirius red) and increased inflammation (CD68-positive cells) within aortic plaques than hyperlipidemic mice (HCi PD). HGHCi-PD mice represent a directly inducible hyperglycemic atherosclerosis model compared with HFD-fed mice, in which atherosclerosis is severe by 8 weeks. Conclusion: We established a nongenetically inducible mouse model allowing comparative analyses of atherosclerosis in HCi and HGHCi conditions and its modification by diet, allowing analyses of multiple metabolic hits in mice.